Spheroids

Drug – bio-affecting and body treating compositions – Preparations characterized by special physical form – Capsules

Patent

Rate now

  [ 0.00 ] – not rated yet Voters 0   Comments 0

Details

424458, 424459, 424488, 424494, A61K 962

Patent

active

048679852

ABSTRACT:
A controlled release pharmaceutical composition contains a number of spheroids, the spheroids containing a water-insoluble drug dispersed in a controlled release matrix. The matrix contains between 70% and 99.5% (by weight) of microcrystalline cellulose, between 0.5% and 4% (by weight) of a cellulose derivative and, optionally, up to 26% of a sugar or a sugar alcohol.
The water insoluble drug must dissolve in water (pH 5) at 20.degree. C. to a concentration of less than 1.0 mg ml-1, preferably less than 0.5 mg ml-1. Preferred drugs are non-steroidal anti-inflammatory agents, especially fenprofen calcium, ibuprofen, ketoprofen, naproxen, diclofenac sodium, fenbufen, flurbiprofen, indomethancin, oxyphenbutazone, phenylbutazone or piroxicam.

REFERENCES:
patent: 4681765 (1987-07-01), Guley

LandOfFree

Say what you really think

Search LandOfFree.com for the USA inventors and patents. Rate them and share your experience with other people.

Rating

Spheroids does not yet have a rating. At this time, there are no reviews or comments for this patent.

If you have personal experience with Spheroids, we encourage you to share that experience with our LandOfFree.com community. Your opinion is very important and Spheroids will most certainly appreciate the feedback.

Rate now

     

Profile ID: LFUS-PAI-O-367708

  Search
All data on this website is collected from public sources. Our data reflects the most accurate information available at the time of publication.